Business combinations (Tables)

9 Months Ended

Sep. 30, 2014

The acquisition-date fair value of the purchase consideration is as follows:

Cash	$	5,093
Common stock		19,348
Contingent consideration		6,550
Total purchase consideration	$	30,991

Estimated Fair Value of Assets Acquired and Liabilities Assumed

The purchase price allocation has been finalized and the following table summarizes the estimated fair value of the assets acquired and liabilities assumed at the date of acquisition:

	Acquisition date fair value
Cash	$	420
Gene editing platform intangible asset		30,100
Goodwill		13,128
Other assets acquired		111
Total assets acquired		43,759
Deferred tax liabilities		11,797
Other liabilities assumed		971
Total liabilities assumed		12,768
Net assets acquired	$	30,991

Estimated Amortization of Intangible Assets

The estimated amortization of intangible assets for the year ended December 31, 2014 and for each of the five succeeding years and thereafter is as follows

2014	$	1,881
2015		3,763
2016		3,763
2017		3,763
2018		3,763
2019 and thereafter		13,167
Total	$	30,100